Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2026-06-09 17:17:05 ET · period of report 2026-06-09 · accession 0001193125-26-264035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-09 17:17 | 2026-06-09 | AXSM | Pizzie Nick | CFO | M - OptEx | $3.50 | +33.0K | 75.9K | +77% | +$115.5K |
| DT | 2026-06-09 17:17 | 2026-06-09 | AXSM | Pizzie Nick | CFO | S - Sale+OE | $240.09 | -33.0K | 42.9K | -43% | -$7.92M |
| DT | 2026-06-09 17:17 | 2026-06-09 | AXSM | Pizzie Nick | CFO | M - OptEx | $0.00 | -33.0K | 72.0K | -31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-09 | M | A | 33,000 | $3.50 | 75,867 | D | — | — | (F1) Represents an exercise of stock options which was held for over 8 years and exercised prior to the 10-year expiration date of such options. (F2) Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed. (F5) Includes the prior purchase of shares of common stock pursuant to the Issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2026-06-09 | S | D | 33,000 | $240.09 | 42,867 | D | — | — | (F2) Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed. (F3) Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options. (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $236.46 and $242.35. (F5) Includes the prior purchase of shares of common stock pursuant to the Issuer's Employee Stock Purchase Plan. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-06-09 | M | D | 33,000 | $0.00 | 72,000 | D | $3.50 · 2019-05-16 to 2028-05-16 | 33,000 Common Stock | (F2) Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed. |